BioDelivery Sciences (BDSI) Misses Q4 EPS by 36c

BioDelivery Sciences (NASDAQ: BDSI) reported Q4 EPS of $0.19, $0.36 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $32.2 million versus the consensus estimate of $52.4 million.

For earnings history and earnings-related data on BioDelivery Sciences (BDSI) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Home Depot beats estimates, reaffirms fiscal 2026 guidance
• Jack Henry (JKHY) Tops Q4 EPS by 13c